ALDH5A1 Antibodies

Santa Cruz Biotechnology features a diverse variety of ALDH5A1 monoclonal antibodies for research focused on understanding ALDH5A1 protein function. ALDH5A1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ALDH5A1, also known as mitochondrial succinic semialdehyde dehydrogenase, plays a crucial role in the metabolism of gamma-aminobutyric acid (GABA) and is involved in the detoxification of succinic semialdehyde. ALDH5A1 maintains GABA homeostasis in the brain, and disruption of normal function has been linked to neurological disorders, including epilepsy and other neurodevelopmental conditions. Research into ALDH5A1 function continues to reveal important insights about its role in neurological health and disease progression. Understanding ALDH5A1 activity and regulation is essential for developing new therapeutic approaches for related disorders. Investigating ALDH5A1 expression patterns helps identify potential biomarkers for early disease detection. Santa Cruz Biotechnology monoclonal antibodies for ALDH5A1 support researchers worldwide in advancing scientific understanding of neurological conditions and potential treatments.